VBI Vaccines Inc. (VBIVQ)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
Oct 30, 2024, 9:59 AM EDT

VBI Vaccines Company Description

VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease.

It offers hepatitis B (HBV) vaccine under the PreHevbrio, PreHevbri, and Sci-B-Vac brand names. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma cancer vaccine immunotherapeutic candidate; VBI-1501, a prophylactic cytomegalovirus vaccine candidate; and VBI-2501 to treat Zika virus.

In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905.

The company has collaboration and license agreements with Brii Biosciences Limited, the National Research Council of Canada, and Coalition for Epidemic Preparedness Innovations.

The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016.

VBI Vaccines Inc. is based in Cambridge, Massachusetts.

VBI Vaccines Inc.
Country Canada
Industry Biotechnology
Sector Healthcare
Employees 138
CEO Jeffery Baxter

Contact Details

Address:
160 Second Street
Cambridge, British Columbia 02142
United States
Phone 617 830 3031
Website vbivaccines.com

Stock Details

Ticker Symbol VBIVQ
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency USD
SIC Code 2836

Key Executives

Name Position
Jeffery R. Baxter FCMA President, Chief Executive Officer and Director
Nell Beattie Chief Financial Officer, Head of Corporate Development and Director
Dr. David Evander Anderson Ph.D. Chief Scientific Officer
Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. Chief Medical Officer
Nicole Anderson Director of Corporate Communications and Investor Relations
Athena Kartsaklis Senior Vice President of Finance, Chief Compliance Officer and Principal Financial Officer
Avi Mazaltov Global Head of Manufacturing and GM of SciVac
Misha Nossov Senior Vice President of Global Commercial Supply Strategy and Head of Europe
T. Adam Buckley B.Sc., MBA Senior Vice President of Business Development
John Robert Dillman Chief Commercial Officer